NEFL and Parkinson disease: Increased blood concentration of NF-L have also been detected in person with frontotemporal dementia (221), Huntington’s disease (222), and Parkinson’s disease (223), suggesting that NF-L may be a biomarker of neurodegenerative processes in general.